Gang Han, colleagues develop tumor-targeting MRI contrast based on human protein

By: Megan Bard / UMass Medical School Communications

A team led by Gang Han, PhD, has designed a human protein-based, tumor-targeting Magnetic Resonance Imaging (MRI) contrast that can be easily cleared by the body. The discovery holds promise for clinical application, including early stage tumor detection because of the enhanced MRI contrast, according to Dr. Han, associate professor of biochemistry & molecular pharmacology.

MRI is one of the most widely used, noninvasive and versatile imaging tools for clinical detection, staging and monitoring of malignancy, without the need for ionizing radiation or harmful radionuclides.

The most frequently employed contrast agents used in MRI are gadolinium (Gd)-based, since they do not provoke an immune response in cells. However, such compounds require high doses of intravenous administration and are retained in the body’s organs.  ... Read More

Read Full Article: http://www.umassmed.edu/news/news-archives/2017/06/gang-han-colleagues-develop-tumor-targeting-mri-contrast-based-on-human-protein/

More about Dr. Gang Han: http://www.umassmed.edu/hanlab

More about Umass Medical School Biochemistry and Molecular Pharmacology: http://www.umassmed.edu/bmp/